JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilton, J. G.
Right arrow Articles by Steinberg, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hilton, J. G.
Right arrow Articles by Steinberg, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 153, Issue 2, 285-291, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF GANGLION- AND PARASYMPATHETIC-BLOCKING DRUGS UPON THE PRESSOR RESPONSE ELICITED BY ELEVATION OF THE INTRACRANIAL FLUID PRESSURE

James G. Hilton 1 and Marshall Steinberg 1

1 Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas

The effects of the ganglion-blocking drug, chlorisondamine, and the parasympatholytic drugs, atropine and valethamate, upon the neurogenic vasoconstriction elicited by elevation of the intracranial fluid pressure have been studied by use of the modified major vessel occlusion technique in dogs anesthetized with pentobarbital sodium. The results of these studies have shown that : 1) the administration of 1.0 mg/kg of chlorisondamine chloride reduces the amount of vasoconstriction which may be elicited by increase in the intracranial fluid pressure, but will not totally block the response; and 2) the administration of either 1.0 mg/kg of atropine or 50.0 µg/kg of valethamate following the administration of chiorisondamine will produce a further blockade of the vasoconstrictor response. The blockade obtained after the combination of a ganglion-blocking drug and a parasympathetic-blocking drug is almost total, and is approximately equivalent to the blockade produced by total spinal anesthesia. It has been concluded from these results that ganglion-blocking drugs do not totally block all physiologic transmission and that an additional sympathetic transmission, apparently ganglionic in nature, sensitive to parasympathetic drugs, exists.

Accepted on February 25, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.